HeimIOBCF • OTCMKTS
add
Ion Beam Applications SA
Við síðustu lokun
15,50 $
Dagbil
15,30 $ - 15,40 $
Árabil
9,52 $ - 15,75 $
Markaðsvirði
431,22 m. EUR
Meðalmagn
408,00
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
EBR
Viðskiptafréttir
CNN
fyrir 7 klukkustundum
Dow sinks sharply as Wall Street gears up for possibility of a Trump victory
0,96%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 103,23 m. | 21,86% |
Rekstrarkostnaður | 36,40 m. | 10,64% |
Nettótekjur | -5,15 m. | 62,21% |
Hagnaðarhlutfall | -4,99 | 68,99% |
Hagnaður á hvern hlut | — | — |
EBITDA | -186,00 þ. | 97,97% |
Virkt skatthlutfall | -51,10% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 60,44 m. | -41,50% |
Heildareignir | 596,16 m. | -2,31% |
Heildarskuldir | 505,87 m. | -3,34% |
Eigið fé alls | 90,28 m. | — |
Útistandandi hlutabréf | 29,16 m. | — |
Eiginfjárgengi | 5,00 | — |
Arðsemi eigna | -0,62% | — |
Ávöxtun eigin fjár | -2,46% | — |
Peningaflæði
Breyting á handbæru fé
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -5,15 m. | 62,21% |
Handbært fé frá rekstri | -25,34 m. | -15,87% |
Reiðufé frá fjárfestingum | -5,40 m. | -58,44% |
Reiðufé frá fjármögnun | 6,38 m. | 497,69% |
Breyting á handbæru fé | -24,56 m. | 10,78% |
Frjálst peningaflæði | -1,87 m. | 79,44% |
Um
IBA is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain and became a university spin-off. It employs about 1500 people in 40 locations. The company developed cyclotrons and integrated proton therapy centers is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation.
IBA installed its first proton therapy equipment for Boston's Massachusetts General Hospital in 2001, and for Philadelphia's Penn Hospital in 2009.
It supplied equipment and services to Proton Partners International which was developing three proton beam therapy centers in the United Kingdom.
In 2017, IBA invested €16 million in the construction of a new logistics and production center in Louvain-la-Neuve. Wikipedia
Framkvæmdastjóri
Stofnsett
1986
Vefsvæði
Starfsfólk
1.943
